BRCA1 and neoplasm: Skin samples were obtained from pathogenic BRCA1 variant carriers and VUS BRCA1 carriers undergoing either risk-reducing mastectomy (K381X, A1708E) or tumour-removal surgery (C61G, G462R, Y856H, D1733G, Q1811K, V1687G) (Fig 1A and 1B).